scorecardresearchMankind Pharma Share Price Live NSE, BSE, Today - Mankind Pharma Stock

Mankind Pharma

BSE: 543904 | NSE: MANKIND | ISIN: INE634S01028 | SECTOR:

1,793.15 28.55 (1.62%)

29 Sep 2023, 10:15 (IST)
  • Open

    1,767.00
  • High

    1,845.05
  • Low

    1,763.00
  • Prev Close

    1,764.60
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    718.32B
  • Volume

    48.81K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    1,793.15

Company Description

  • BSE

    543904
  • NSE

    MANKIND
  • ISIN

    INE634S01028

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

Company Officers

  • Ramesh Juneja

    Executive Chairman of the Board
  • Sheetal Arora

    Chief Executive Officer, Whole-Time Director
  • Rajeev Juneja

    Executive Vice Chairman of the Board, Managing Director
  • Ashutosh Dhawan

    Chief Financial Officer
  • Arjun Juneja

    Chief Operating Officer
  • Pradeep Chugh

    Compliance Officer, Company Secretary
  • Satish Sharma

    Whole-Time Director